Abstract
We present a patient with anti-MDA5 negative, anti- Ku positive clinically amyopathic dermatomyositis (CADM). A 61-year-old woman presented with a chief complaint of a 20-year history of a pruritic rash that was active on her face, chest, hands, legs, and back. A mildly scaly, erythematous, photo-distributed eruption along with slightly violaceous, scaly papules accentuated on the wrist, metacarpophalangeal joints, proximal interphalangeal and distal interphalangeal joints. Antibody profile was significant for positive ANA and anti-dsDNA, elevated anti-TIF-1gamma (RDL)/p155, and weakly positive anti Ku. Biopsy was consistent with dermatomyositis. Melanoma differentiation-associated gene 5 antibody (anti-MDA-5) has been identified as the most commonly associated autoantibody found in CADM and is associated with poor prognosis and a biomarker for the diagnosis of rapidly progressive interstitial lung disease. To our knowledge, our patient is the first case of negative anti-MDA-5 and anti-Ku positive CADM.
Author supplied keywords
Cite
CITATION STYLE
Carrington, A. E., Tartar, D. M., & Sivamani, R. K. (2021). Anti-mda-5 negative, anti-ku positive clinically amyopathic dermatomyositis. Dermatology Online Journal, 27(4). https://doi.org/10.5070/d3274053154
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.